No new round recorded in 190 months.

1. 05 Nov 2010

   Seed

   €352K

   Cumulative €352K

Amounts in EUR, converted at the ECB rate on the event date. Funding totals exclude debt, grants and state aid; rounds whose instrument is not yet established are still counted. Every figure links to its source.

• Launch09 Jun 2026

  Cellin Technologies is advancing a cell-therapy treatment that stimulates the body to grow new blood vessels, helping patients avoid amputation.

  ▸Source: pmo.ee

  “For decades, physicians have battled vascular calcification, but there comes a point when even the most advanced treatments are no longer effective. That is when an idea that sounds almost like…”

  Read at pmo.ee

• Funding05 Nov 2010EUR 352K

  Cellin Technologies received a seed investment of about EUR 352,000 from the Estonian Development Fund and an unnamed co-investor to support stem cell research, together acquiring a one-third stake in the company. This is a historical round from November 2010 that predates the company's tracked events.

  ▸Source: baltic-course.com

  Read at baltic-course.com

• Dr. Andrus Loog

  Chairman of the Supervisory Board

• Dr. Ivar Järving

  Responsible Person on GMP

Raised €352K to date · FY2024 turnover €4K · 6 employees

• Turnover grew 65% FY2023→FY2024.
• Headcount 5 → 6 over FY2022→FY2023.

What does Cellin Technologies do?

Company advancing cell-therapy treatment

Where is Cellin Technologies headquartered?

Cellin Technologies is based in Estonia.

How much funding has Cellin Technologies raised?

Cellin Technologies has raised €352K (across 1 round · last 05 Nov 2010).

What was Cellin Technologies's latest funding round?

Cellin Technologies's most recent disclosed round was a seed round of €352K, announced 5 November 2010.

What is Cellin Technologies's revenue?

Cellin Technologies reported €4K in turnover for FY2024, per official registry filings.